Philip Shaw1, Meaghan Malek, Bethany Watson, Deanna Greenstein, Pietro de Rossi, Wendy Sharp. 1. Section on Neurobehavioral Clinical Research, Social and Behavioral Research Branch, National Human Genome Research Institute, Bethesda, Maryland; Intramural Program of the National Institute of Mental Health, Bethesda, Maryland. Electronic address: shawp@mail.nih.gov.
Abstract
BACKGROUND: Childhood attention-deficit/hyperactivity disorder (ADHD) persists into adulthood in around half of those affected, constituting a major public health challenge. No known demographic, clinical, or neuropsychological factors robustly explain the clinical course, directing our focus to the brain. Herein, we link the trajectories of cerebral cortical development during childhood and adolescence with the severity of adult ADHD. METHODS: Using a longitudinal study design, 92 participants with ADHD had childhood (mean 10.7 years, SD 3.3) and adult clinical assessments (mean 23.8 years, SD 4.3) with repeated neuroanatomic magnetic resonance imaging. Contrast was made against 184 matched typically developing volunteers. RESULTS: Attention-deficit/hyperactivity disorder persisted in 37 (40%) subjects and adult symptom severity was linked to cortical trajectories. Specifically, as the number of adult symptoms increased, particularly inattentive symptoms, so did the rate of cortical thinning in the medial and dorsolateral prefrontal cortex. For each increase of one symptom of adult ADHD, the rate of cortical thinning increased by .0018 mm (SE = .0004, t = 4.2, p < .0001), representing a 5.6% change over the mean rate of thinning for the entire group. These differing trajectories resulted in a convergence toward typical dimensions among those who remitted and a fixed, nonprogressive deficit in persistent ADHD. Notably, cortical thickening or minimal thinning (greater than -.007 mm/year) was found exclusively among individuals who remitted. CONCLUSIONS: Adult ADHD status is linked with the developmental trajectories of cortical components of networks supporting attention, cognitive control, and the default mode network. This informs our understanding of the developmental pathways to adult ADHD. Published by Elsevier Inc on behalf of Society of Biological Psychiatry.
BACKGROUND: Childhood attention-deficit/hyperactivity disorder (ADHD) persists into adulthood in around half of those affected, constituting a major public health challenge. No known demographic, clinical, or neuropsychological factors robustly explain the clinical course, directing our focus to the brain. Herein, we link the trajectories of cerebral cortical development during childhood and adolescence with the severity of adult ADHD. METHODS: Using a longitudinal study design, 92 participants with ADHD had childhood (mean 10.7 years, SD 3.3) and adult clinical assessments (mean 23.8 years, SD 4.3) with repeated neuroanatomic magnetic resonance imaging. Contrast was made against 184 matched typically developing volunteers. RESULTS:Attention-deficit/hyperactivity disorder persisted in 37 (40%) subjects and adult symptom severity was linked to cortical trajectories. Specifically, as the number of adult symptoms increased, particularly inattentive symptoms, so did the rate of cortical thinning in the medial and dorsolateral prefrontal cortex. For each increase of one symptom of adult ADHD, the rate of cortical thinning increased by .0018 mm (SE = .0004, t = 4.2, p < .0001), representing a 5.6% change over the mean rate of thinning for the entire group. These differing trajectories resulted in a convergence toward typical dimensions among those who remitted and a fixed, nonprogressive deficit in persistent ADHD. Notably, cortical thickening or minimal thinning (greater than -.007 mm/year) was found exclusively among individuals who remitted. CONCLUSIONS: Adult ADHD status is linked with the developmental trajectories of cortical components of networks supporting attention, cognitive control, and the default mode network. This informs our understanding of the developmental pathways to adult ADHD. Published by Elsevier Inc on behalf of Society of Biological Psychiatry.
Authors: Christian K Tamnes; Ylva Ostby; Anders M Fjell; Lars T Westlye; Paulina Due-Tønnessen; Kristine B Walhovd Journal: Cereb Cortex Date: 2009-06-11 Impact factor: 5.357
Authors: Jean-Baptiste Pingault; Richard E Tremblay; Frank Vitaro; René Carbonneau; Christophe Genolini; Bruno Falissard; Sylvana M Côté Journal: Am J Psychiatry Date: 2011-07-28 Impact factor: 18.112
Authors: Benjamin B Lahey; William E Pelham; Jan Loney; Heidi Kipp; Ashley Ehrhardt; Steve S Lee; Erik G Willcutt; Cynthia M Hartung; Andrea Chronis; Greta Massetti Journal: Am J Psychiatry Date: 2004-11 Impact factor: 18.112
Authors: Chandra Sripada; Saige Rutherford; Mike Angstadt; Wesley K Thompson; Monica Luciana; Alexander Weigard; Luke H Hyde; Mary Heitzeg Journal: Mol Psychiatry Date: 2019-08-19 Impact factor: 15.992
Authors: Agatha Lenartowicz; Arnaud Delorme; Patricia D Walshaw; Alex L Cho; Robert M Bilder; James J McGough; James T McCracken; Scott Makeig; Sandra K Loo Journal: J Neurosci Date: 2014-01-22 Impact factor: 6.167
Authors: Joel T Nigg; Jennifer M Jester; Gillian M Stavro; Ka I Ip; Leon I Puttler; Robert A Zucker Journal: Neuropsychology Date: 2017-01-16 Impact factor: 3.295
Authors: Anita D Barber; Deepak K Sarpal; Majnu John; Christina L Fales; Stewart H Mostofsky; Anil K Malhotra; Katherine H Karlsgodt; Todd Lencz Journal: Biol Psychiatry Date: 2019-02-06 Impact factor: 13.382